Matches in Wikidata for { <http://www.wikidata.org/entity/Q65330792> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q65330792 description "clinical trial" @default.
- Q65330792 description "ensayu clínicu" @default.
- Q65330792 description "klinisch onderzoek" @default.
- Q65330792 description "клінічне випробування" @default.
- Q65330792 description "կլինիկական փորձարկում" @default.
- Q65330792 name "Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression" @default.
- Q65330792 name "Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression" @default.
- Q65330792 type Item @default.
- Q65330792 label "Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression" @default.
- Q65330792 label "Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression" @default.
- Q65330792 prefLabel "Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression" @default.
- Q65330792 prefLabel "Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression" @default.
- Q65330792 P1050 Q65330792-7DC42411-35B4-48F9-88CF-21FE7337F83F @default.
- Q65330792 P1132 Q65330792-964E28E1-4AE9-4D16-982D-2C2125277CE5 @default.
- Q65330792 P1476 Q65330792-D28F2E59-7193-4BFD-AD1E-F03C66684AB4 @default.
- Q65330792 P17 Q65330792-2D2C2914-C5EF-4832-B044-C3C41933605C @default.
- Q65330792 P2899 Q65330792-3FF88244-C682-4900-802B-70CCDA0A3D1E @default.
- Q65330792 P3098 Q65330792-9C03438E-6E11-4951-99E1-D4FE23C37BAE @default.
- Q65330792 P31 Q65330792-4F6DBAAD-1C9D-4E51-8352-7CC4E1EDA498 @default.
- Q65330792 P580 Q65330792-855A0DF2-D2D8-4C39-BEF5-95D2D9DF0E67 @default.
- Q65330792 P582 Q65330792-F6365F56-372A-45CC-8333-AC8AFE01E21D @default.
- Q65330792 P6099 Q65330792-CD3917E7-13CB-4119-BA36-9460777FC5A1 @default.
- Q65330792 P6099 Q65330792-D4E3AA70-3764-4876-815C-9942D03EF167 @default.
- Q65330792 P6153 Q65330792-246778D6-89DF-4512-AEC9-038EEF789BA9 @default.
- Q65330792 P6153 Q65330792-41675D54-BFC9-42BE-980E-5A74395BDBD9 @default.
- Q65330792 P6153 Q65330792-44BA64B8-EA98-47EF-A7C7-0AEF0AE72DB6 @default.
- Q65330792 P6153 Q65330792-7C2348CD-0A4A-4400-B283-E068528CE99C @default.
- Q65330792 P8363 Q65330792-DBBA96D0-4611-46BB-BC00-12617E17291D @default.
- Q65330792 P1050 Q33525 @default.
- Q65330792 P1132 "+90" @default.
- Q65330792 P1476 "Randomized Phase IB/II Study of Enzalutamide With and Without Ribociclib in Patients With Metastatic Castrate Resistant, Chemotherapy Naïve Prostate Cancer That Retains RB Expression" @default.
- Q65330792 P17 Q30 @default.
- Q65330792 P2899 "+18" @default.
- Q65330792 P3098 "NCT02555189" @default.
- Q65330792 P31 Q30612 @default.
- Q65330792 P580 "2015-12-01T00:00:00Z" @default.
- Q65330792 P582 "2020-04-14T00:00:00Z" @default.
- Q65330792 P6099 Q42824440 @default.
- Q65330792 P6099 Q5452194 @default.
- Q65330792 P6153 Q1808012 @default.
- Q65330792 P6153 Q230492 @default.
- Q65330792 P6153 Q2471216 @default.
- Q65330792 P6153 Q7370121 @default.
- Q65330792 P8363 Q78089383 @default.